CRVS
Corvus Pharmaceuticals Inc.
Company Overview
| Mkt Cap | $437.40M | Price | $8.04 |
| Volume | 1.89M | Change | +3.61% |
| P/E Ratio | -7.0 | Open | $7.76 |
| Revenue | -- | Prev Close | $7.76 |
| Net Income | $-62.3M | 52W Range | $2.54 - $10.00 |
| Div Yield | N/A | Target | $15.00 |
| Overall | 59 | Value | 50 |
| Quality | 39 | Technical | 90 |
No chart data available
Stock Overview
Updated DailyCorvus Pharmaceuticals Inc. (CRVS) is a leading Healthcare company in the Biotechnology industry, currently trading at $8.04 with a market capitalization of $437.40 million. The stock is positioned in the upper portion of its trading range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows CRVS with a volume of 1.89 million shares. The stock opened down 0.00% from yesterday's close of $7.76. Current analyst estimates project earnings of $-0.51 per share for this year, with next year targeting $-0.6.
CRVS demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for CRVS include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 86.6%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 07:19 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CRVS | $8.04 | +3.6% | 1.89M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corvus Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW